This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

I-MED, Harrison.ai, Annalise.ai won't be probed over privacy claims: Australian watchdog

( August 1, 2025, 01:41 GMT | Official Statement) -- MLex Summary: Australia’s privacy regulator has closed its preliminary inquiries against I-MED radiology Network, Harrison.ai and Annalise.ai, after concluding the diagnostic-imaging network had de-identified shared patient data sufficiently to ensure that it was “no longer personal information for the purposes of the Privacy Act.” In a statement, the Office of the Australian Information Commissioner also said that I-MED had “processed the data using a number of techniques” and had imposed contractual obligations on Annalise.ai to protect patients’ privacy. “The Commissioner therefore ceased the inquiries and will not be pursuing regulatory action at this time,” the watchdog said in a statement. The inquiries were sparked by media reports in September 2024.The full report of the OAIC's preliminary inquiries is attached and the regulator's media statement is below: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login